mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
XMD8-85 |
GDSC1000 |
pan-cancer |
AAC |
0.056 |
0.3 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.3 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.3 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |